{"nct_id":"NCT03284424","title":"Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)","status":"COMPLETED","status_verified_date":"2024-07","start_date":"2017-10-26","start_date_type":"ACTUAL","primary_completion_date":"2020-07-29","primary_completion_date_type":"ACTUAL","completion_date":"2023-09-13","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}